ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2089

Deviation of T and B Cell Subset and Its Association with Single Nucleotide Polymorphisms in Patients with Antiphospholipid Syndrome

Ryo Hisada1, Masaru Kato1, Hisako Nakagawa2, Eri Sugawara1, Masatoshi Kanda1, Kazumasa Ohmura1, Ikuma Nakagawa1, Kenji Oku1, Toshiyuki Bohgaki1, Olga Amengual1, Tetsuya Horita1, Shinsuke Yasuda1 and Tatsuya Atsumi1, 1Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 2Department of Probiotics Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: antiphospholipid syndrome and genome, B cells, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Antiphospholipid Syndrome - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Antiphospholipid syndrome (APS) is a well-characterized autoimmune and thrombotic disorder but its pathogenesis remains to be elucidated. Genomic studies have revealed the association of signal transducer and activator of transcription 4 (STAT4) and B lymphoid kinase (BLK) with APS, suggesting the involvement of T cell differentiation and B cell maturation in the development of APS. However, little information has been available on the role of T and B cells in the pathogenesis of APS. We aimed to identify the deviation of lymphocyte subset and its association with single nucleotide polymorphisms (SNPs) in APS patients.

Methods: This cross-sectional study included patients with primary APS (PAPS), APS associated with systemic lupus erythematosus (SLE/APS) and healthy controls. Peripheral blood mononuclear cells and genomic DNA were obtained from these subjects. T cells were analyzed into 12 subsets with markers as follows; CD3, CD4, CD25, CD45RA, CD127, CD45RA, CCR6, CCR7, CXCR3, CXCR5. B cells were analyzed into 6 subsets with markers as follows; CD3, CD4, CD24, CD27, CD38, IgD. In addition, a total of 28 SNPs, which had been shown to associate either with SLE or with thrombotic diseases, were analyzed by TaqMan genotyping assay.

Results: Seventeen PAPS, eight SLE/APS patients and eight healthy controls were included in this study. In T cell analysis, Th2 cells (CD3+CD4+CD45RA–CCR6–CXCR3–CXCR5–) were increased in PAPS (p = 0.016, Dunnett’s test) and SLE/APS (p = 0.013) patients compared to healthy controls. Resting regulatory T cells (CD4+CD25int/highCD45RA+CD127low) were decreased in PAPS patients compared to healthy controls (p = 0.017). In B cell analysis, pre-switched memory B cells (CD3–CD19+ CD27+IgD+) and post-switched memory B cells (CD3–CD19+CD27+IgD–) were simultaneously decreased in PAPS patients compared to healthy controls (p = 0.022 and p = 0.016, respectively). In SNPs analysis, one of Toll-like receptor 7 gene polymorphisms (rs3853839) was associated with the decrease of post-switched memory B cells observed in PAPS patients (p = 0.038).

Conclusion: In APS patients, Th2 cells were increased while resting regulatory T cells, pre- and post-switched memory B cells were decreased. Furthermore, association between Toll-like receptor 7 and a decrease of memory B cells was found in APS patients. The deviation in lymphocyte subsets in patients with APS could be, in part, immunogenetically regulated, presumably contributing to the development of this syndrome.


Disclosure: R. Hisada, None; M. Kato, None; H. Nakagawa, None; E. Sugawara, None; M. Kanda, None; K. Ohmura, None; I. Nakagawa, None; K. Oku, None; T. Bohgaki, None; O. Amengual, None; T. Horita, None; S. Yasuda, Bristol Myers Squibb, 2; T. Atsumi, Astellas, Takeda, Mitsubishi Tanabe, Chugai, Daiichi Sankyo, Otsuka, Pfizer, 2,Mitsubishi Tanabe, Chugai, Astellas, Takeda, Pfizer, Eisai, Abbvie, 8.

To cite this abstract in AMA style:

Hisada R, Kato M, Nakagawa H, Sugawara E, Kanda M, Ohmura K, Nakagawa I, Oku K, Bohgaki T, Amengual O, Horita T, Yasuda S, Atsumi T. Deviation of T and B Cell Subset and Its Association with Single Nucleotide Polymorphisms in Patients with Antiphospholipid Syndrome [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/deviation-of-t-and-b-cell-subset-and-its-association-with-single-nucleotide-polymorphisms-in-patients-with-antiphospholipid-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deviation-of-t-and-b-cell-subset-and-its-association-with-single-nucleotide-polymorphisms-in-patients-with-antiphospholipid-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology